KERALA AYURVEDA
|
The Current P/E Ratio of KERALA AYURVEDA is 145.64.
Share Price | ₹415.0 | Jan 02,2025 |
Market Cap | ₹497.9 Cr | |
Earnings-TTM | ₹3.4 Cr | TTM-Consolidated Results |
Price/Earnings | 145.64x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KERALA AYURVEDA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹497.9 Cr] as on Jan 02,2025
(/) Earnings [ ₹3.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 145.64x ]
Thus, for KERALA AYURVEDA , the investors are currently willing to pay 145.64 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KERALA AYURVEDA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KERALA AYURVEDA over the last five years.
Historical PE (Price/Earnings) ratio chart of KERALA AYURVEDA
PE Ratio Performance Analysis for KERALA AYURVEDA
- KERALA AYURVEDA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.97x.
- KERALA AYURVEDA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KERALA AYURVEDA 's p/e ratio peaked in Mar2022 at 34.93x.
- KERALA AYURVEDA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does KERALA AYURVEDA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KERALA AYURVEDA | 3.42 | 145.64 | 497.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 40.46 | 450,595.0 |
CIPLA LTD | 4,485.22 | 27.69 | 124,175.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 21.20 | 114,625.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.19 | 99,672.5 |
DIVIS LABORATORIES LTD | 1,836.00 | 88.83 | 163,089.0 |
MANKIND PHARMA LTD | 2,124.86 | 56.30 | 119,626.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 64.73 | 116,637.0 |
LUPIN LTD | 2,651.94 | 41.23 | 109,327.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 21.77 | 78,329.8 |
ABBOTT INDIA LTD | 1,284.66 | 49.53 | 63,622.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KERALA AYURVEDA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 21.20x |
Max industry PE | 145.64x |
Median industry PE | 41.23x |
Average industry PE | 52.78x |
You may also like the below Video Courses